National Heart, Lung, and Blood Institute; Amended Notice of Meeting, 50334 [E8-19672]

Download as PDF 50334 Federal Register / Vol. 73, No. 166 / Tuesday, August 26, 2008 / Notices Bethesda, MD, 20892 which was published in the Federal Register on July 31, 2008, FRE8–17517. The meeting is open to the public from 1–1:30 p.m. and closed to the public from 1:30–3 p.m. The rest of the information remains the same. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Mentored Clinical Scientist Development and Independent Scientist Awards. Date: September 18–19, 2008. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Marriott Crystal City, 1999 Jefferson Davis Highway, Arlington, VA 22202. Contact Person: Rina Das, PhD, Scientific Review Administrator, Review Branch/ DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7200, Bethesda, MD 20892–7924, 301–435–0297, dasr2@nhlbi.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: August 19, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–19671 Filed 8–25–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health sroberts on PROD1PC76 with NOTICES National Heart, Lung, and Blood Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Heart, Lung, and Blood Advisory Council, September 9, 2008, 1 p.m. to 3 p.m., National Institutes of Health, Building 31, 31 Center Drive, Conference Room 10, VerDate Aug<31>2005 00:53 Aug 26, 2008 Jkt 214001 Dated: August 19, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–19672 Filed 8–25–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Environmental Health Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Environmental Health SciencesSpecial Emphasis Panel; Superfund Basic Research and Training Program Administrative Meeting. Date: September 24, 2008. Time: 2:00 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: NIEHS/National Institutes of Health Building 4401, East Campus, 79 T.W. Alexander Drive, Research Triangle Park, NC 27709 (telephone conference call). Contact Person: Linda K Bass, PhD, Scientific Review Officer, Scientific Review Branch, Division of Extramural Research and Training, Natl Institute Environmental Health Sciences, P.O. Box 12233, MD EC–30, Research Triangle Park, NC 27709, (919) 541– 1307. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS) Dated: Aug 19, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–19670 Filed 8–25–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Agency Information Collection Activities: Submission for OMB Review; Comment Request Periodically, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish a summary of information collection requests under OMB review, in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these documents, call the SAMHSA Reports Clearance Officer at (240) 276–1243. Project: Drug Abuse Warning Network (OMB No. 0930–0078)—Revision The Drug Abuse Warning Network (DAWN) is an ongoing data system that collects information on drug-related medical emergencies as reported from about 350 hospitals nationwide, and drug-related deaths as reported from 11 states with centralized Medical Examiner offices and 125 medical examiners/coroner jurisdictions (ME/C) in 32 metropolitan areas. DAWN provides national and metropolitan estimates of substances involved with drug-related emergency department (ED) visits; disseminates information about substances involved in deaths investigated by participating medical examiners and coroners (ME/Cs); tracks drug abuse patterns, trends, and the emergence of new substances; monitors post-market adverse drug incidents; assesses health hazards associated with the use of illicit, prescription, and overthe-counter drugs; and generates information for national and local drug abuse policy and program planning. DAWN data are used by Federal, State, and local agencies, as well as universities, pharmaceutical companies, and the media. From 2009 to 2011, DAWN will continue to recruit hospitals in the 13 oversampled metropolitan areas and in the remainder of the U.S. in order to improve the precision of estimates, adding approximately 43 sampled hospitals that are currently not C:\FR\FM\26AUN1.SGM 26AUN1

Agencies

[Federal Register Volume 73, Number 166 (Tuesday, August 26, 2008)]
[Notices]
[Page 50334]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-19672]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Amended Notice of 
Meeting

    Notice is hereby given of a change in the meeting of the National 
Heart, Lung, and Blood Advisory Council, September 9, 2008, 1 p.m. to 3 
p.m., National Institutes of Health, Building 31, 31 Center Drive, 
Conference Room 10, Bethesda, MD, 20892 which was published in the 
Federal Register on July 31, 2008, FRE8-17517.
    The meeting is open to the public from 1-1:30 p.m. and closed to 
the public from 1:30-3 p.m. The rest of the information remains the 
same.

    Dated: August 19, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
 [FR Doc. E8-19672 Filed 8-25-08; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.